Colorectal Cancer Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Colorectal Cancer stocks.

Colorectal Cancer Stocks Recent News

Date Stock Title
Nov 1 SNY Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ...
Nov 1 MYGN Myriad Genetics plummets 20% as UnitedHealth changes GeneSight coverage
Nov 1 SNY Kymera Q3 Loss Narrower Than Expected, Pipeline in Focus
Nov 1 CCCC C4 Therapeutics Third Quarter 2024 Earnings: Beats Expectations
Nov 1 REGN What Makes Regeneron Pharmaceuticals (REGN) an Attractive Investment Opportunity?
Nov 1 REGN Regeneron Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
Nov 1 REGN Regeneron: Investors In Panic Mode On Increased Eylea Fears
Nov 1 REGN Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug
Nov 1 EXAS Exact Sciences to Participate in November Investor Conference
Nov 1 SNY Kymera Therapeutics Inc (KYMR) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...
Nov 1 REGN Regeneron Pharmaceuticals Inc (REGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...
Nov 1 REGN Q3 2024 Regeneron Pharmaceuticals Inc Earnings Call
Oct 31 NKTR Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets
Oct 31 REGN Regeneron Pharmaceuticals files automatic mixed securities shelf
Oct 31 REGN Eylea headwinds said to be behind Regeneron’s post-Q3 plunge
Oct 31 REGN Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
Oct 31 REGN Regeneron Pharmaceuticals, Inc. (REGN) Q3 2024 Earnings Call Transcript
Oct 31 REGN Regeneron down 10% despite top and bottom line beats
Oct 31 REGN Regeneron Takes A Ghastly Turn As High-Dose Eylea Lags And Biosimilars Loom
Oct 31 REGN Regeneron (REGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Colorectal Cancer

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time.Most colorectal cancers are due to old age and lifestyle factors, with only a small number of cases due to underlying genetic disorders. Some risk factors include diet, obesity, smoking, and lack of physical activity. Dietary factors that increase the risk include red meat, processed meat, and alcohol. Another risk factor is inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis. Some of the inherited genetic disorders that can cause colorectal cancer include familial adenomatous polyposis and hereditary non-polyposis colon cancer; however, these represent less than 5% of cases. It typically starts as a benign tumor, often in the form of a polyp, which over time becomes cancerous.Bowel cancer may be diagnosed by obtaining a sample of the colon during a sigmoidoscopy or colonoscopy. This is then followed by medical imaging to determine if the disease has spread. Screening is effective for preventing and decreasing deaths from colorectal cancer. Screening, by one of a number of methods, is recommended starting from the age of 50 to 75. During colonoscopy, small polyps may be removed if found. If a large polyp or tumor is found, a biopsy may be performed to check if it is cancerous. Aspirin and other non-steroidal anti-inflammatory drugs decrease the risk. Their general use is not recommended for this purpose, however, due to side effects.Treatments used for colorectal cancer may include some combination of surgery, radiation therapy, chemotherapy and targeted therapy. Cancers that are confined within the wall of the colon may be curable with surgery, while cancer that has spread widely are usually not curable, with management being directed towards improving quality of life and symptoms. The five-year survival rate in the United States is around 65%. The individual likelihood of survival depends on how advanced the cancer is, whether or not all the cancer can be removed with surgery and the person's overall health. Globally, colorectal cancer is the third most common type of cancer, making up about 10% of all cases. In 2012, there were 1.4 million new cases and 694,000 deaths from the disease. It is more common in developed countries, where more than 65% of cases are found. It is less common in women than men.

Browse All Tags